Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study

Addict Behav. 2019 Jun:93:246-249. doi: 10.1016/j.addbeh.2019.02.013. Epub 2019 Feb 14.

Abstract

Repetitive Transcranial Magnetic Stimulation (rTMS) shows the potential to modulate local brain activity, thus resulting in a modulatory action on neurocircuitries implicated in the pathophysiology of Gambling Disorder (GD). We report the case of a GD patient treated with two weeks of high frequency (15 Hz) rTMS over the dorsolateral prefrontal cortex (DLPFC). At baseline and after rTMS treatment the patient underwent a SPECT examination with (123)I-FP-CIT tracer, to test changes in dopamine transporter (DAT) availability. The patient was followed up for six months, to explore safety and clinical correlates of a weekly high frequency rTMS maintenance treatment. Over the six-month follow-up the patient reported no episodes of gambling relapse. Also, the patient did not report craving for gambling or gambling-related symptoms. After two weeks of left DLPFC-rTMS treatment, we found a decrease in DAT availability in striatal regions, that represents a putative neurobiological substrate of dopaminergic pathways modulation. This study suggests that high frequency DLPFC-rTMS deserves further investigations in larger samples, using controlled study designs, to assess its real potential as a treatment for GD.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Caudate Nucleus / diagnostic imaging*
  • Caudate Nucleus / metabolism
  • Craving
  • Dopamine Plasma Membrane Transport Proteins / metabolism*
  • Gambling / diagnostic imaging
  • Gambling / metabolism
  • Gambling / therapy*
  • Humans
  • Male
  • Neostriatum / diagnostic imaging
  • Neostriatum / metabolism
  • Prefrontal Cortex*
  • Putamen / diagnostic imaging*
  • Putamen / metabolism
  • Recurrence
  • Tomography, Emission-Computed, Single-Photon
  • Transcranial Magnetic Stimulation / methods*
  • Tropanes

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane